MX2012002456A - Nuevas formas de un compuesto multiciclico. - Google Patents
Nuevas formas de un compuesto multiciclico.Info
- Publication number
- MX2012002456A MX2012002456A MX2012002456A MX2012002456A MX2012002456A MX 2012002456 A MX2012002456 A MX 2012002456A MX 2012002456 A MX2012002456 A MX 2012002456A MX 2012002456 A MX2012002456 A MX 2012002456A MX 2012002456 A MX2012002456 A MX 2012002456A
- Authority
- MX
- Mexico
- Prior art keywords
- novel forms
- multicyclic compound
- compound
- multicyclic
- forms
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23718009P | 2009-08-26 | 2009-08-26 | |
| PCT/US2010/046671 WO2011028580A1 (en) | 2009-08-26 | 2010-08-25 | Novel forms of a multicyclic compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012002456A true MX2012002456A (es) | 2012-05-08 |
Family
ID=43033463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012002456A MX2012002456A (es) | 2009-08-26 | 2010-08-25 | Nuevas formas de un compuesto multiciclico. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8633314B2 (enExample) |
| EP (1) | EP2470540B1 (enExample) |
| JP (3) | JP2013503173A (enExample) |
| KR (1) | KR20120092100A (enExample) |
| CN (1) | CN102482282A (enExample) |
| AU (1) | AU2010289746B2 (enExample) |
| BR (1) | BR112012004053A2 (enExample) |
| CA (1) | CA2772328C (enExample) |
| CL (1) | CL2012000478A1 (enExample) |
| DK (1) | DK2470540T3 (enExample) |
| EA (1) | EA020756B1 (enExample) |
| ES (1) | ES2572652T3 (enExample) |
| IL (1) | IL218132B (enExample) |
| MX (1) | MX2012002456A (enExample) |
| MY (1) | MY156873A (enExample) |
| NZ (1) | NZ598883A (enExample) |
| SG (1) | SG178852A1 (enExample) |
| UA (1) | UA110604C2 (enExample) |
| WO (1) | WO2011028580A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA020756B1 (ru) * | 2009-08-26 | 2015-01-30 | Сефалон, Инк. | Новые формы полициклического соединения |
| AU2015353549A1 (en) * | 2014-11-26 | 2017-06-01 | Cephalon, Inc. | Crystalline forms of PARP inhibitors |
| EP3478286B1 (en) | 2016-06-29 | 2024-01-03 | Tesaro, Inc. | Methods of treating ovarian cancer |
| MX2019011496A (es) | 2017-03-27 | 2020-01-23 | Tesaro Inc | Composiciones de niraparib. |
| BR112020006039A2 (pt) | 2017-09-26 | 2020-10-06 | Tesaro, Inc. | formulações de niraparibe |
| CN109632555B (zh) * | 2018-12-28 | 2021-07-27 | 上海新黄河制药有限公司 | 一种富马酸福莫特罗无定型含量的动态蒸汽吸附分析方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7122679B2 (en) * | 2000-05-09 | 2006-10-17 | Cephalon, Inc. | Multicyclic compounds and the use thereof |
| US20060276497A1 (en) | 2000-05-09 | 2006-12-07 | Cephalon, Inc. | Novel multicyclic compounds and the use thereof |
| CA2620052A1 (en) * | 2005-08-24 | 2007-03-01 | Inotek Pharmaceuticals Corporation | Indenoisoquinolinone analogs and methods of use thereof |
| CN101784268B (zh) * | 2006-11-20 | 2013-06-19 | 赛福伦公司 | 使用辐射敏化剂使肿瘤对辐射敏化的方法 |
| EA020756B1 (ru) * | 2009-08-26 | 2015-01-30 | Сефалон, Инк. | Новые формы полициклического соединения |
-
2010
- 2010-08-25 EA EA201270315A patent/EA020756B1/ru not_active IP Right Cessation
- 2010-08-25 CA CA2772328A patent/CA2772328C/en not_active Expired - Fee Related
- 2010-08-25 MX MX2012002456A patent/MX2012002456A/es active IP Right Grant
- 2010-08-25 MY MYPI2012000710A patent/MY156873A/en unknown
- 2010-08-25 EP EP10750210.6A patent/EP2470540B1/en active Active
- 2010-08-25 WO PCT/US2010/046671 patent/WO2011028580A1/en not_active Ceased
- 2010-08-25 CN CN2010800380284A patent/CN102482282A/zh active Pending
- 2010-08-25 NZ NZ598883A patent/NZ598883A/en not_active IP Right Cessation
- 2010-08-25 UA UAA201203501A patent/UA110604C2/uk unknown
- 2010-08-25 DK DK10750210.6T patent/DK2470540T3/en active
- 2010-08-25 AU AU2010289746A patent/AU2010289746B2/en not_active Ceased
- 2010-08-25 BR BR112012004053-7A patent/BR112012004053A2/pt not_active IP Right Cessation
- 2010-08-25 ES ES10750210.6T patent/ES2572652T3/es active Active
- 2010-08-25 SG SG2012012290A patent/SG178852A1/en unknown
- 2010-08-25 JP JP2012526945A patent/JP2013503173A/ja active Pending
- 2010-08-25 KR KR1020127007524A patent/KR20120092100A/ko not_active Ceased
-
2012
- 2012-02-15 IL IL218132A patent/IL218132B/en not_active IP Right Cessation
- 2012-02-24 CL CL2012000478A patent/CL2012000478A1/es unknown
- 2012-02-24 US US13/404,137 patent/US8633314B2/en not_active Expired - Fee Related
-
2015
- 2015-07-30 JP JP2015151114A patent/JP2016014029A/ja not_active Ceased
-
2017
- 2017-09-04 JP JP2017169876A patent/JP2018035158A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011028580A1 (en) | 2011-03-10 |
| EA201270315A1 (ru) | 2012-08-30 |
| CA2772328A1 (en) | 2011-03-10 |
| CL2012000478A1 (es) | 2012-11-05 |
| JP2016014029A (ja) | 2016-01-28 |
| MY156873A (en) | 2016-04-15 |
| CN102482282A (zh) | 2012-05-30 |
| UA110604C2 (uk) | 2016-01-25 |
| AU2010289746A1 (en) | 2012-04-12 |
| KR20120092100A (ko) | 2012-08-20 |
| ES2572652T3 (es) | 2016-06-01 |
| AU2010289746B2 (en) | 2016-07-07 |
| JP2013503173A (ja) | 2013-01-31 |
| DK2470540T3 (en) | 2016-08-01 |
| EP2470540A1 (en) | 2012-07-04 |
| NZ598883A (en) | 2014-09-26 |
| EA020756B1 (ru) | 2015-01-30 |
| US20120214998A1 (en) | 2012-08-23 |
| US8633314B2 (en) | 2014-01-21 |
| BR112012004053A2 (pt) | 2020-12-08 |
| JP2018035158A (ja) | 2018-03-08 |
| EP2470540B1 (en) | 2016-04-20 |
| CA2772328C (en) | 2017-06-20 |
| IL218132A0 (en) | 2012-06-28 |
| HK1171750A1 (zh) | 2013-04-05 |
| IL218132B (en) | 2018-02-28 |
| SG178852A1 (en) | 2012-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG148142A1 (en) | Aryloazol-2-yl cyanoethylamino compunds, method of making and method of using thereof | |
| CL2012000590A1 (es) | Proceso para preparar w-transaminasa (r)-selectiva. | |
| MX344786B (es) | Composiciones y metodos para tratar enfermedad de gaucher. | |
| GEP20135898B (en) | Rifaximin forms and usage | |
| MY179933A (en) | Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use thereof | |
| MX339878B (es) | Nuevas formas solidas de clorhidrato de bendamustina. | |
| EA201171318A1 (ru) | Улучшение улавливания углерода при ферментации | |
| EA201170465A1 (ru) | Способы лечения прогрессирующего множественного склероза | |
| EA201270280A1 (ru) | Соединения пиримидина в качестве ингибиторов при лечении туберкулеза | |
| PH12013500554A1 (en) | Process for preparing pan-cdk inhibitors of the formula (i) and intermediates in the preparation | |
| MX337486B (es) | Fibras de degradacion controlada. | |
| MY151104A (en) | Novel use | |
| MY155330A (en) | Methods for salt production | |
| MX2012002456A (es) | Nuevas formas de un compuesto multiciclico. | |
| MX337357B (es) | Excipiente para tableteado a base de lactosa y celulosa. | |
| TW201129620A (en) | New formaldehyde scavengers | |
| EA201290801A1 (ru) | Способ получения сциллоинозита | |
| MX2011013735A (es) | Procedimiento de preparacion de alquilalcanolaminas. | |
| MY183354A (en) | (r)-6-(dimthylamino)-4,4-diphenylheptan-3-one | |
| MX2012010317A (es) | ß-HIDROXIALQUILAMIDAS, METODO PARA SU PRODUCCION Y SU USO. | |
| MX2012007283A (es) | Composiciones para vacunas. | |
| MX2013006166A (es) | Fibras degradables. | |
| EA201101613A1 (ru) | Способ получения севеламера | |
| GB2477452A (en) | A visual aid | |
| UA41936U (ru) | Способ лечения крауроза вульвы в детском возрасте |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |